Indivior Pharmaceuticals Inc. Common Stock vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $68.94 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 80.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Vanguard Tax Managed Fund FTSE Developed Markets ETF is more actively traded (10,680,748 versus 2,781,171). Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 132 Days on average.
| INDV | VEA | |
|---|---|---|
Market Cap | $4.03B | $323.80B |
Volume | 2,781,171 | 10,680,748 |
Sector | Health | — |
52-Week High | $41.83 | $73.79 |
52-Week Low | $24.09 | $58.90 |
Typical Hold Time | 0 Days | 132 Days |
Enterprise Value | $4.32B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VEA trades at $70.06, up 0.16% today, with a bearish technical signal driven by moving averages. The ETF offers exposure to developed markets outside the U.S. with a low 0.03% expense ratio and a dividend yield. Recent institutional activity is mixed, with some firms increasing stakes while others reduced positions.
The outlook is neutral to cautious given bearish technicals and mixed sentiment. Key opportunities include cost efficiency and diversification benefits, but risks involve global market volatility and currency fluctuations. Investors should weigh the ETF's low-cost structure against broader economic uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →